View in EDS

Key considerations for advancing chimeric antigen receptor (CAR) T-cell therapy for systemic lupus erythematosus (SLE): a multi-partner/disciplinary working group perspective.

Saved in:
Bibliographic Details
Title: Key considerations for advancing chimeric antigen receptor (CAR) T-cell therapy for systemic lupus erythematosus (SLE): a multi-partner/disciplinary working group perspective.
Authors: Hsieh EWY; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA lupusabc@lupusresearch.org., Chung JB; Amgen Inc, Thousand Oaks, California, USA., Amin A; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Askanase AD; Columbia University Irving Medical Center, New York, New York, USA., Bartok B; Gilead Sciences Inc, Foster City, California, USA., Brunetta P; Sana Biotechnology Inc, Seattle, Washington, USA., Carrasco-Alfonso MJ; AstraZeneca, Boston, Massachusetts, USA., Coney C; Lupus Voices Council, Lupus Research Alliance, New York, New York, USA., Cooper JC; Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Dall'Era M; University of California San Francisco, San Francisco, California, USA., Delev N; Bristol Myers Squibb Co, Princeton, New Jersey, USA., Eldred A; AbbVie Inc, North Chicago, Illinois, USA., Furie RA; Division of Rheumatology, Northwell Health, Great Neck, New York, USA., Garces S; Bristol Myers Squibb Co, Princeton, New Jersey, USA., Groover K; Michigan Lupus Foundation, Traverse City, Michigan, USA., Harrington M; Fluent in Science, LLC, New York, New York, USA., Hogan JJ; Cabaletta Bio Inc, Philadelphia, Pennsylvania, USA., Imperato GH; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Jackson M; Lupus Research Alliance, New York, New York, USA., Jackson SW; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, Washington, USA., Jongco AM; GlaxoSmithKline, Philadelphia, Pennsylvania, USA., Karis E; Nkarta Inc, South San Francisco, California, USA., Koegel A; Bristol Myers Squibb Co, Princeton, New Jersey, USA., König MF; Division of Rheumatology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Ludwig Center, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA., Koretzky G; Cornell University, Ithaca, New York, USA., Kumar V; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Morand E; School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.; Monash Health, Clayton, Victoria, Australia., Payne AS; Columbia University Irving Medical Center, New York, New York, USA., Popat V; Center for Biologics Research and Evaluation, US Food and Drug Administration, Silver Spring, Maryland, USA., Rizvi N; Synthekine Inc, Menlo Park, California, USA., Rohan P; Division of Allergy, Immunology, and Transplantation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA., Sadelain M; Columbia University Irving Medical Center, New York, New York, USA., Schett G; Department of Medicine 3-Rheumatology and Immunology and Deutshes Zentrum Immuntherapie, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, BY, Germany.; Universitatsklinikum Erlangen, Erlangen, BY, Germany., Singh AP; Takeda Pharmaceuticals America Inc, Cambridge, Massachusetts, USA., van Vollenhoven RF; Department of Rheumatology, Amsterdam University Medical Center, Amsterdam, Netherlands., Zack D; Fate Therapeutics Inc, San Diego, California, USA.
Corporate Authors: Lupus ABC CAR T Working Group
Source: RMD open [RMD Open] 2025 Oct 05; Vol. 11 (4). Date of Electronic Publication: 2025 Oct 05.
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Electronic Cited Medium: Internet ISSN: 2056-5933 (Electronic) Linking ISSN: 20565933 NLM ISO Abbreviation: RMD Open Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41052891
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Key considerations for advancing chimeric antigen receptor (CAR) T-cell therapy for systemic lupus erythematosus (SLE): a multi-partner/disciplinary working group perspective.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hsieh+EWY%22">Hsieh EWY</searchLink>; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA lupusabc@lupusresearch.org.<br /><searchLink fieldCode="AU" term="%22Chung+JB%22">Chung JB</searchLink>; Amgen Inc, Thousand Oaks, California, USA.<br /><searchLink fieldCode="AU" term="%22Amin+A%22">Amin A</searchLink>; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Askanase+AD%22">Askanase AD</searchLink>; Columbia University Irving Medical Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Bartok+B%22">Bartok B</searchLink>; Gilead Sciences Inc, Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Brunetta+P%22">Brunetta P</searchLink>; Sana Biotechnology Inc, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Carrasco-Alfonso+MJ%22">Carrasco-Alfonso MJ</searchLink>; AstraZeneca, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Coney+C%22">Coney C</searchLink>; Lupus Voices Council, Lupus Research Alliance, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Cooper+JC%22">Cooper JC</searchLink>; Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.<br /><searchLink fieldCode="AU" term="%22Dall'Era+M%22">Dall'Era M</searchLink>; University of California San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Delev+N%22">Delev N</searchLink>; Bristol Myers Squibb Co, Princeton, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Eldred+A%22">Eldred A</searchLink>; AbbVie Inc, North Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Furie+RA%22">Furie RA</searchLink>; Division of Rheumatology, Northwell Health, Great Neck, New York, USA.<br /><searchLink fieldCode="AU" term="%22Garces+S%22">Garces S</searchLink>; Bristol Myers Squibb Co, Princeton, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Groover+K%22">Groover K</searchLink>; Michigan Lupus Foundation, Traverse City, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Harrington+M%22">Harrington M</searchLink>; Fluent in Science, LLC, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Hogan+JJ%22">Hogan JJ</searchLink>; Cabaletta Bio Inc, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Imperato+GH%22">Imperato GH</searchLink>; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Jackson+M%22">Jackson M</searchLink>; Lupus Research Alliance, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Jackson+SW%22">Jackson SW</searchLink>; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Jongco+AM%22">Jongco AM</searchLink>; GlaxoSmithKline, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Karis+E%22">Karis E</searchLink>; Nkarta Inc, South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Koegel+A%22">Koegel A</searchLink>; Bristol Myers Squibb Co, Princeton, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22König+MF%22">König MF</searchLink>; Division of Rheumatology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Ludwig Center, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Koretzky+G%22">Koretzky G</searchLink>; Cornell University, Ithaca, New York, USA.<br /><searchLink fieldCode="AU" term="%22Kumar+V%22">Kumar V</searchLink>; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Morand+E%22">Morand E</searchLink>; School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.; Monash Health, Clayton, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Payne+AS%22">Payne AS</searchLink>; Columbia University Irving Medical Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Popat+V%22">Popat V</searchLink>; Center for Biologics Research and Evaluation, US Food and Drug Administration, Silver Spring, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Rizvi+N%22">Rizvi N</searchLink>; Synthekine Inc, Menlo Park, California, USA.<br /><searchLink fieldCode="AU" term="%22Rohan+P%22">Rohan P</searchLink>; Division of Allergy, Immunology, and Transplantation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Sadelain+M%22">Sadelain M</searchLink>; Columbia University Irving Medical Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Schett+G%22">Schett G</searchLink>; Department of Medicine 3-Rheumatology and Immunology and Deutshes Zentrum Immuntherapie, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, BY, Germany.; Universitatsklinikum Erlangen, Erlangen, BY, Germany.<br /><searchLink fieldCode="AU" term="%22Singh+AP%22">Singh AP</searchLink>; Takeda Pharmaceuticals America Inc, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22van+Vollenhoven+RF%22">van Vollenhoven RF</searchLink>; Department of Rheumatology, Amsterdam University Medical Center, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Zack+D%22">Zack D</searchLink>; Fate Therapeutics Inc, San Diego, California, USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Lupus+ABC+CAR+T+Working+Group%22">Lupus ABC CAR T Working Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101662038%22">RMD open</searchLink> [RMD Open] 2025 Oct 05; Vol. 11 (4). <i>Date of Electronic Publication: </i>2025 Oct 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group%22">BMJ Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101662038 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2056-5933 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220565933%22">20565933 </searchLink><i>NLM ISO Abbreviation: </i>RMD Open <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41052891
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/rmdopen-2025-005866
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Key considerations for advancing chimeric antigen receptor (CAR) T-cell therapy for systemic lupus erythematosus (SLE): a multi-partner/disciplinary working group perspective.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hsieh EWY
      – PersonEntity:
          Name:
            NameFull: Chung JB
      – PersonEntity:
          Name:
            NameFull: Amin A
      – PersonEntity:
          Name:
            NameFull: Askanase AD
      – PersonEntity:
          Name:
            NameFull: Bartok B
      – PersonEntity:
          Name:
            NameFull: Brunetta P
      – PersonEntity:
          Name:
            NameFull: Carrasco-Alfonso MJ
      – PersonEntity:
          Name:
            NameFull: Coney C
      – PersonEntity:
          Name:
            NameFull: Cooper JC
      – PersonEntity:
          Name:
            NameFull: Dall'Era M
      – PersonEntity:
          Name:
            NameFull: Delev N
      – PersonEntity:
          Name:
            NameFull: Eldred A
      – PersonEntity:
          Name:
            NameFull: Furie RA
      – PersonEntity:
          Name:
            NameFull: Garces S
      – PersonEntity:
          Name:
            NameFull: Groover K
      – PersonEntity:
          Name:
            NameFull: Harrington M
      – PersonEntity:
          Name:
            NameFull: Hogan JJ
      – PersonEntity:
          Name:
            NameFull: Imperato GH
      – PersonEntity:
          Name:
            NameFull: Jackson M
      – PersonEntity:
          Name:
            NameFull: Jackson SW
      – PersonEntity:
          Name:
            NameFull: Jongco AM
      – PersonEntity:
          Name:
            NameFull: Karis E
      – PersonEntity:
          Name:
            NameFull: Koegel A
      – PersonEntity:
          Name:
            NameFull: König MF
      – PersonEntity:
          Name:
            NameFull: Koretzky G
      – PersonEntity:
          Name:
            NameFull: Kumar V
      – PersonEntity:
          Name:
            NameFull: Morand E
      – PersonEntity:
          Name:
            NameFull: Payne AS
      – PersonEntity:
          Name:
            NameFull: Popat V
      – PersonEntity:
          Name:
            NameFull: Rizvi N
      – PersonEntity:
          Name:
            NameFull: Rohan P
      – PersonEntity:
          Name:
            NameFull: Sadelain M
      – PersonEntity:
          Name:
            NameFull: Schett G
      – PersonEntity:
          Name:
            NameFull: Singh AP
      – PersonEntity:
          Name:
            NameFull: van Vollenhoven RF
      – PersonEntity:
          Name:
            NameFull: Zack D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 05
              M: 10
              Text: 2025 Oct 05
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2056-5933
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: RMD open
              Type: main
ResultId 1